Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction
Archana Panikkar(QIMR Berghofer Medical Research Institute), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Michelle Wykes(QIMR Berghofer Medical Research Institute), Alan B. Rickinson(Birmingham City University), Denis J. Moss(The University of Queensland), Andrew D. Hislop(University of Birmingham), Vijayendra Dasari(QIMR Berghofer Medical Research Institute), Nick Tellam(QIMR Berghofer Medical Research Institute), Corey Smith(QIMR Berghofer Medical Research Institute), Henry H. Balfour(University of Minnesota System), Kristin A. Hogquist(University of Minnesota Medical Center)
Cited by 24
Related Papers
Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis
|Cancer|1979|1.1k
T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse
|The Journal of Experimental Medicine|2011|1k
Immune checkpoint blockade in infectious diseases
|Nature reviews. Immunology|2017|571
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332